Handelsbanken Fonder AB Buys 1,100 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Handelsbanken Fonder AB boosted its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 7.6% in the fourth quarter, Holdings Channel reports. The firm owned 15,581 shares of the company’s stock after purchasing an additional 1,100 shares during the quarter. Handelsbanken Fonder AB’s holdings in Prestige Consumer Healthcare were worth $1,217,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. JPMorgan Chase & Co. raised its position in shares of Prestige Consumer Healthcare by 3.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 272,255 shares of the company’s stock valued at $19,630,000 after buying an additional 8,533 shares in the last quarter. Geode Capital Management LLC increased its stake in Prestige Consumer Healthcare by 4.0% in the third quarter. Geode Capital Management LLC now owns 1,326,794 shares of the company’s stock valued at $95,678,000 after acquiring an additional 50,961 shares during the last quarter. Avior Wealth Management LLC raised its position in Prestige Consumer Healthcare by 1,570.7% during the fourth quarter. Avior Wealth Management LLC now owns 8,554 shares of the company’s stock valued at $668,000 after purchasing an additional 8,042 shares in the last quarter. Barclays PLC lifted its stake in Prestige Consumer Healthcare by 346.3% during the third quarter. Barclays PLC now owns 92,444 shares of the company’s stock worth $6,665,000 after purchasing an additional 71,730 shares during the last quarter. Finally, Assenagon Asset Management S.A. boosted its holdings in shares of Prestige Consumer Healthcare by 171.6% in the 4th quarter. Assenagon Asset Management S.A. now owns 46,931 shares of the company’s stock valued at $3,665,000 after purchasing an additional 29,649 shares in the last quarter. Institutional investors own 99.95% of the company’s stock.

Wall Street Analysts Forecast Growth

PBH has been the subject of a number of research analyst reports. Raymond James raised Prestige Consumer Healthcare to a “moderate buy” rating in a report on Thursday, December 19th. StockNews.com raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Friday, January 24th. Sidoti downgraded shares of Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price target on the stock. in a research note on Monday, December 9th. DA Davidson lifted their price target on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a report on Friday, February 7th. Finally, Oppenheimer increased their price objective on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a research note on Thursday, February 13th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $92.60.

Prestige Consumer Healthcare Stock Down 1.3 %

PBH stock opened at $86.26 on Thursday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68. The stock’s 50 day simple moving average is $79.67 and its 200 day simple moving average is $76.89. The company has a market cap of $4.27 billion, a P/E ratio of 20.20, a price-to-earnings-growth ratio of 2.69 and a beta of 0.50. Prestige Consumer Healthcare Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $88.36.

Prestige Consumer Healthcare (NYSE:PBH) last posted its earnings results on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. On average, research analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.